Public Profile

Valeant Canada Ltd.

Valeant Canada Ltd., a prominent player in the pharmaceutical and biotechnology industry, is headquartered in Canada. Founded in 1960, the company has established itself as a leader in specialty pharmaceuticals, focusing on dermatology, ophthalmology, and neurology. With a strong presence in North America and expanding operations in international markets, Valeant is known for its innovative approach to drug development and patient care. The company’s core products include a diverse range of prescription medications and over-the-counter treatments, distinguished by their efficacy and unique formulations. Valeant's commitment to research and development has led to significant milestones, including strategic acquisitions that enhance its product portfolio. Recognised for its market resilience, Valeant Canada Ltd. continues to make strides in improving health outcomes while maintaining a strong competitive position in the global pharmaceutical landscape.

DitchCarbon Score

How does Valeant Canada Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

30

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Valeant Canada Ltd.'s score of 30 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Valeant Canada Ltd.'s reported carbon emissions

Valeant Canada Ltd., headquartered in CA, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their climate impact or commitments. However, the company may be engaged in various initiatives to address climate change, as is common in the pharmaceutical industry. Many companies in this sector are increasingly focusing on sustainability and reducing their carbon footprint through innovative practices and technologies. Valeant's commitment to environmental responsibility may align with industry trends, but specific details on their climate strategies or targets are not provided.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Valeant Canada Ltd.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Valeant Canada Ltd. is in CA, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Valeant Canada Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Sandoz Canada Inc.

CA
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Hls Pharmacies, Inc.

US
Retail trade services, except of motor vehicles and motorcycles; repair services of personal and household goods (52)
Updated 1 day ago

Teva Canada Limited

CA
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Janssen Inc.

CA
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Viatris

US
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Bristol Myers Squibb Canada Co.

CA
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers